My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Suzlon Energy gains after winning new orders
Sep 23,2016

The announcement was made during market hours today, 23 September 2016.

Meanwhile, the S&P BSE Sensex was down 11.78 points or 0.04% at 28,761.35.

On BSE, so far 18.24 lakh shares were traded in the counter as against average daily volume of 38.63 lakh shares in the past one quarter. The stock hit a high of Rs 16.30 and a low of Rs 15.80 so far during the day. The stock had hit a 52-week high of Rs 25.25 on 2 November 2015. The stock had hit a 52-week low of Rs 12.80 on 12 February 2016. The stock had underperformed the market over the past one month till 22 September 2016, falling 3.65% compared with Sensexs 2.81% gains. The scrip also underperformed the market in past one quarter, dropping 7.58% as against Sensexs 7.5% gains.

The mid-cap company has equity capital of Rs 1004.88 crore. Face value per share is Rs 2.

Suzlon Energy said that the combined capacity included orders from reputed corporate houses such as Serum Institute of India, Rajasthan Gum Group and an assortment of small & medium enterprises (SME) customers. The corporate and SME orders have been received from mixed bag of customers across diverse industry segments. Suzlon will provide the entire spectrum of turnkey solutions right from equipment supply till commissioning and also offer dedicated life cycle asset management services for a contractually defined period to these customers. The projects are spread across the key windy states of Andhra Pradesh, Gujarat, Karnataka and Tamil Nadu and are scheduled to be completed by March 2017.

On a consolidated basis, Suzlon Energy reported net loss of Rs 259.97 crore in Q1 June 2016 compared with net profit of Rs 1014.34 crore in Q1 June 2015. Net sales declined 36.2% to Rs 1649.58 crore in Q1 June 2016 over Q1 June 2015.

The Suzlon Group is one of the leading renewable energy solutions providers in the world with an international presence across 19 countries. The company has recently forayed into the solar space.

Powered by Capital Market - Live News

Bhel advances after optimistic management comments
Sep 23,2016

The announcement was made after market hours yesterday, 22 September 2016.

Meanwhile, the S&P BSE Sensex was down 19.89 points or 0.07% at 28,753.24

On BSE, so far 5.75 lakh shares were traded in the counter as against average daily volume of 10.74 lakh shares in the past one quarter. The stock hit a high of Rs 150.70 and a low of Rs 146.40 so far during the day. The stock had hit a 52-week low of Rs 90.40 on 29 February 2016. The stock had hit a 52-week high of Rs 219.70 on 27 October 2015. The stock had outperformed the market over the past 30 days till 22 September 2016, rising 7.57% compared with 2.54% rise in the Sensex. The scrip also outperformed the market in past one quarter, surging 24.4% as against Sensexs 9% rise.

The large-cap company has equity capital of Rs 489.52 crore. Face value per share is Rs 2.

Bharat Heavy Electricals (Bhel)s chairman & managing director, Atul Sobti, said that in spite of financial year ended 31 March 2016 (FY 2016) being an extremely challenging year, the company recorded the highest-ever commissioning of projects in its history and the highest order booking in the last five years in FY 2016, ending the year with significant traction in growth drivers.

Addressing shareholders at the 52nd annual general meeting of the company, Sobti said that enhanced focus on project execution has resulted in Bhel creating history by way of commissioning/synchronizing an all-time high 15,059 megawatts (MW) of power generating equipment during the year. Despite intense competitive pressure in the power and capital goods markets during the year, Bhel achieved the highest order booking in the last five years, at Rs 43727 crore, a 42% leap over 2014-2015. The company ended the year with a total order book of Rs 110730 crore for execution in 2016-2017 and beyond.

Bharat Heavy Electricals (Bhel)s net profit jumped 54.2% to Rs 77.77 crore on 29% growth in net sales to Rs 5522.76 crore in Q1 June 2016 over Q1 June 2015.

State-run Bhel is an integrated power plant equipment manufacturer. It is one of the largest engineering and manufacturing companies in India engaged in the design, engineering, manufacture, construction, testing, commissioning and servicing of a wide range of products and services for core sectors of the economy, viz. power, transmission, industry, railways, renewable energy, oil & gas, water and defence. The Government of India currently holds 63.06% stake in Bhel (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

L&T Technology Services trades with small premium on debut
Sep 23,2016

Meanwhile, the BSE Sensex was down 13.45 points, or 0.05%, to 28,759.68.

L&T Technology Services made its debut on the bourses at Rs 900, a premium of 4.65% over the offer price of Rs 860. On BSE, so far 10.63 lakh shares were traded in the counter. The stock hit a high of Rs 931 and low of Rs 886.95 so far during the day.

The initial public offer (IPO) of L&T Technology Services received bids for 1.83 crore shares and the IPO was subscribed 2.53 times. The IPO of L&T Technology Services was opened on 12 September 2016 and closed on 15 September 2016.

The IPO comprised of an offer for sale of 1.04 crore shares by engineering and construction major L&T. L&T Technology Services will not receive any funds from the IPO. L&Ts stake in L&T Technology Services has fallen to 89.77% from 100% earlier after the L&T Technologys IPO.

L&T Technology Services provides Engineering, Research and Development (ER&D) services to manufacturing, technology and process engineering companies, to help them develop and build products, processes and infrastructure required to deliver products and services to their end customers. The company operates in five industry segments viz. transportation, industrial products, telecom and hi-tech, process industry and medical devices. The company derives majority of its revenue from the US and Europe which are the two largest regions of corporate ER&D spend. North America contributed 60.4% of revenue from operations and Europe contributed 19.8% of revenue from operations for the year ended 31 March 2016 (FY 2016).

Based on consolidated financials, L&T Technology Services reported net profit of Rs 135.05 crore on revenue from operations of Rs 765.38 crore for the quarter ended 30 June 2016. The company reported net profit of Rs 434.23 crore on revenue from operations of Rs 2894.03 crore for FY 2016.

Powered by Capital Market - Live News

Adlabs Entertainment jumps as Insync Capital Partners LLP buys shares
Sep 23,2016

Meanwhile, the S&P BSE Sensex, was currently off 30.22 points or 0.11% at 28,742.91

On BSE, so far 5.81 lakh shares were traded in the counter, compared with average daily volume of 76,676 shares in the past one quarter. The stock hit high of Rs 99.90 and low of Rs 94.80 so far during the trading session. The stock had hit 52-week high of Rs 145.40 on 31 December 2015. The stock had hit all-time low of Rs 68 on 29 February 2016. The stock had underperformed the market over the past 30 days till 22 September 2016, rising 1.95% compared with 2.54% rise in the Sensex. The scrip, however, outperformed the market in past one quarter, rising 9.65% as against Sensexs 9% rise.

The small-cap company has equity capital of Rs 79.90 crore. Face value per share is Rs 10.

Adlabs Entertainment reported net loss of Rs 19.23 crore in Q1 June 2016, higher than net loss of Rs 15.52 crore in Q1 June 2015. Net sales rose 7.25% to Rs 83.10 crore in Q1 June 2016 over Q1 June 2015.

Insync Capital Partners LLP bought 4 lakh shares of Adlabs Entertainment at an average price of Rs 81.84 per share in a bulk deal on NSE yesterday, 22 September 2016. Insync Capital Partners LLP sold 50,000 shares of Adlabs Entertainment at an average price of Rs 81.06 per share in a bulk deal on NSE yesterday, 22 September 2016.

Adlabs Entertainment operates the Imagica theme park located at Khalapur, off the Mumbai-Pune express highway.

Powered by Capital Market - Live News

Jubilant Life Sciences gains after its subsidiary proposes to raise funds
Sep 23,2016

The announcement was made during market hours today, 23 September 2016.

Meanwhile, the BSE Sensex was down 13.45 points, or 0.05%, to 28,759.68.

On BSE, so far 1.12 lakh shares were traded in the counter, compared with average daily volume of 2.43 lakh shares in the past one quarter. The stock hit a high of Rs 648, so far during the day, which is a record high for the stock. The stock hit a low of Rs 623.50 so far during the day. The stock hit a 52-week low of Rs 272.50 on 20 January 2016. The stock had outperformed the market over the past one month till 22 September 2016, rising 22.55% compared with Sensexs 2.81% gains. The scrip also outperformed the market in past one quarter, surging 85.12% as against Sensexs 7.5% gains.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences said that the board of directors of companys material wholly-owned subsidiary, Jubilant Pharma (JPL) at a meeting held today, 23 September 2016, approved the proposal to launch a benchmark offering of unsecured high yield bonds (notes) outside India by JPL. The notes are proposed to be listed on the Singapore Exchange Securities Trading. Jubilant Pharma is a company incorporated under the laws of Singapore outside India.

Jubilant Life Sciences consolidated net profit rose 22.5% to Rs 161.60 crore on 1.7% decline in net sales to Rs 1400.97 crore in Q1 June 2016 over Q1 June 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and drug discovery solutions. The companys strength lies in its unique offerings of pharmaceuticals and life sciences products and services across the value chain.

Powered by Capital Market - Live News

Morepen Laboratories soars on reports of likely sale of OTC brands
Sep 23,2016

Meanwhile, the S&P BSE Sensex was down 15.34 points, or 0.05%, to 28,757.59

On BSE, so far 10.07 lakh shares were traded in the counter, compared with average daily volume of 4.33 lakh shares in the past one quarter. The stock hit a high of Rs 27.25 and a low of Rs 26.10 so far during the day. The stock hit a 52-week high of Rs 41.80 on 5 January 2016. The stock hit a 52-week low of Rs 13.14 on 23 September 2015. The stock had outperformed the market over the past 30 days till 22 September 2016, rising 25.25% compared with 2.54% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, rising 8.3% as against Sensexs 9% rise.

The small-cap drug maker has an equity capital of Rs 89.97 crore. Face value per share is Rs 2.

As per reports, Morepen Laboratories is considering a business rejig which could lead to a potential sale of the over-the-counter brands, including antiseptic cream Burnol. The companys OTC portfolio include Lemolate cold and cough relief remedy , Sat-Isabgol, anti-fungal and antibacterial cream Itch Beat, Fever-X, Pain-X, a face wash and 2 Cool hair oil, among other brands. Piramal Healthcare, Cipla and Zydus Cadila could be among the potential suitors, reports indicated.

Morepen Laboratories net profit surged 60.4% to Rs 4.01 crore on 17.57% rise in net sales to Rs 116.72 crore in Q1 June 2016 over Q1 June 2015.

Morepen Laboratories is a pharmaceutical company having four divisions including active pharmaceutical ingredient (API), domestic formulations, diagnostics and over the counter (OTC).

Powered by Capital Market - Live News

Shriram Transport Finance Company gains after raising funds
Sep 23,2016

The announcement was made after market hours yesterday, 22 September 2016.

Meanwhile, the BSE Sensex was down 20.02 points, or 0.05% to 28,758.81.

On BSE, so far 12,615 shares were traded in the counter, compared with an average volume of 50,742 shares in the past one quarter. The stock hit high of Rs 1,214 and low of Rs 1,196.90 so far during the day. The stock hit a 52-week high of Rs 1,325 on 1 August 2016. The stock hit a 52-week low of Rs 736.50 on 21 January 2016. The stock had underperformed the market over the past one month till 22 September 2016, falling 7.08% compared with Sensexs 2.81% gains. The scrip also underperformed the market in past one quarter, rising 2.79% as against Sensexs 7.5% gains.

The large-cap company has an equity capital of Rs 226.88 crore. Face value per share is Rs 10.

Shriram Transport Finance Company said that allotment committee of the company in its meeting held on 22 September 2016 allotted 1,300 secured, redeemable non-convertible debentures (NCDs) of face value of Rs 10 lakh each, aggregating to Rs 130 crore on private placement basis. The NCDs have tenure of three years from the date of allotment. The NCDs carry a coupon rate of 8.25% per annum.

Shriram Transport Finance Companys net profit rose 16.5% to Rs 374.10 crore on 14.1% rise in total income to Rs 2685.99 crore in Q1 June 2016 over Q1 June 2015.

Shriram Transport Finance Company is the largest asset financing non banking financial company (NBFC). The company is a leader in organized financing of pre-owned trucks with strategic presence in 5-12 year old trucks.

Powered by Capital Market - Live News

Majesco advances after entering into agreement with Glemham
Sep 23,2016

The announcement was made after market hours yesterday, 22 September 2016.

Meanwhile, the S&P BSE Sensex was down 25.68 points or 0.09% at 28,747.45

On BSE, so far 16,000 shares were traded in the counter as against average daily volume of 26,338 shares in the past one quarter. The stock hit a high of Rs 488 and a low of Rs 476 so far during the day. The stock had hit a record high of Rs 789 on 12 January 2016. The stock had hit a record low of Rs 303 on 29 September 2015.

The small-cap company has equity capital of Rs 11.62 crore. Face value per share is Rs 5.

Majesco announced that it has entered into an agreement with Glemham, a UK based managing general agent (MGA), to create a new cloud based bureau processing business using Majesco CloudInsurer to reduce the cost of transacting General Insurance in the UK market. Majesco CloudInsurer platform will be used to initially provide commercial lines insurance to both the broker and the small medium enterprise (SME) markets. Based on the Majesco CloudInsurer platform, the business will deliver Net Rated products to all distribution channels, supporting full cycle processing across the Internet. Capacity is being provided by a number of different underwriters. Processing expense ratio in the business is expected to be around 5% versus the typical 14%-18% seen across the market.

Majesco CloudInsurer provides a core insurance software platform leveraging Majesco core solutions with a digital, multi-channel platform leveraging Majesco.

Majescos net profit fell 64.96% to Rs 0.89 crore on 10.47% rise in total income to Rs 8.97 crore in Q1 June 2016 over Q4 March 2016.

Majesco enables insurance business transformation for about 150 insurance customers worldwide by providing solutions which include software, consulting and services.

Powered by Capital Market - Live News

GPPL slips after bulk deal
Sep 22,2016

Meanwhile, the S&P BSE Sensex was up 245 points, or 0.86%, to 28,770.33

Bulk deal boosted volume in the Gujarat Pipavav Port (GPPL) scrip. On BSE, so far 19.40 lakh shares were traded in the counter, compared with average daily volume of 1.13 lakh shares in the past one quarter. The stock hit a high of Rs 185 and a low of Rs 170.05 so far during the day. The stock hit a 52-week high of Rs 212.50 on 9 October 2015. The stock hit a 52-week low of Rs 136.60 on 30 December 2015. The stock had underperformed the market over the past 30 days till 21 September 2016, falling 1.14% compared with 1.85% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 4.83% as against Sensexs 5.57% rise.

The mid-cap company has an equity capital of Rs 483.44 crore. Face value per share is Rs 10.

Gujarat Pipavav Port (GPPL)s net profit rose 60.45% to Rs 59.75 crore on 10.24% fall in net sales to Rs 154.67 crore in Q1 June 2016 over Q1 June 2015.

GPPL is managed and operated by APM Terminals, the ports and terminals company of the maritime giant, the A.P. Moller-Maersk Group. APM Terminals is one of the largest container terminal operators in the world and offers the global shipping community an integrated Global Terminal Network of 56 ports and 154 inland facilities in 63 countries.

Powered by Capital Market - Live News

Reliance Defence gains after emerging as lowest bidder for building partol vessels
Sep 22,2016

Meanwhile, the S&P BSE Sensex was up 286.90 points, or 1.01%, to 28,794.32

On BSE, so far 14.17 lakh shares were traded in the counter, compared with average daily volume of 6.72 lakh shares in the past one quarter. The stock hit a high of Rs 61.45 and a low of Rs 59.70 so far during the day. The stock hit a 52-week high of Rs 114 on 28 December 2015. The stock hit a 52-week low of Rs 52.65 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 September 2016, falling 9.79% compared with 1.85% rise in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 8.1% as against Sensexs 5.57% rise.

The mid-cap company has equity capital of Rs 736.21 crore. Face value per share is Rs 10.

In a clarification to reports indicating that the company has won bid to build 14 Fast Patrol Vessels, Reliance Defence and Engineering during market hours today, 22 September 2016 clarified that it has emerged as the lowest bidder to build 14 Fast Patrol Vessels for the Indian Coast Guard (ICG). The approximate order value is Rs 920 crore, Reliance Defence and Engineering said.

Reliance Defence & Engineering reported net loss of Rs 134.50 crore in Q1 June 2016, lower than net loss of Rs 167.27 crore in Q1 June 2015. Reliance Defence & Engineerings total income dropped 34.21% to Rs 74.18 crore in Q1 June 2016 over Q1 June 2015.

Reliance Defence & Engineering (formerly Pipavav Defence and Offshore Engineering Company) is into building defence warships.

Powered by Capital Market - Live News

HDFC Bank gains after raising funds through debenture issue
Sep 22,2016

The announcement was made during market hours today, 22 September 2016.

Meanwhile, the S&P BSE Sensex was down 121.23 points or 0.43% at 27,794.66.

On BSE, so far 78,132 shares were traded in the counter as against average daily volume of 1.15 lakh shares in the past one quarter. The stock hit high of Rs 1,315.55 and low of Rs 1,300.30 so far during the day.

HDFC Bank said that it allotted 67,000 senior, unsecured, redeemable, long-term non-convertible bonds in the nature of debentures having face value of Rs 10 lakh each amounting to Rs 6700 crore on a private placement basis.

HDFC Banks net profit rose 20.2% to Rs 3238.91 crore on 17.1% growth in total income to Rs 19322.63 crore in Q1 June 2016 over Q1 June 2015.

HDFC Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

IT stocks decline as rupee strengthens
Sep 22,2016

Meanwhile, the S&P BSE Sensex was up 249.56 points or 0.88% at 28,755.86.

HCL Technologies (down 0.26%), Tech Mahindra (down 1.37%), TCS (down 1.1%) and Wipro (down 0.47%) declined. Oracle Financial Services Software rose 0.2%. A firm rupee adversely affects operating profit margins of IT firms as the sector derives a lions share of revenue from exports.

In the foreign exchange market, the partially convertible rupee was currently hovering at 66.7675, compared with closing of 67.02 during the previous trading session.

The BSE IT index had underperformed the market over the past one month till 21 September 2016, falling 1.57% compared with 1.53% rise in the Sensex. The index had also underperformed the market in past one quarter, dropping 10.09% as against Sensexs 6.32% rise.

Powered by Capital Market - Live News

Federal Bank advances after twin bulk deals
Sep 22,2016

A bulk deal of 34.04 lakh shares was executed on the Federal Bank scrip at Rs 72.65 per share at 10:17 IST on BSE. Another bulk deal of 25.32 lakh shares was executed on the scrip at Rs 73.10 per share at 10:26 IST on BSE.

Meanwhile, the S&P BSE Sensex was up 243.21 points or 0.85% at 28,750.63

Bulk deal boosted volume on the scrip. On BSE, so far 97.25 lakh shares were traded in the counter as against average daily volume of 7.71 lakh shares in the past one quarter. The stock hit a high of Rs 73.85 and a low of Rs 71.20 so far during the day. The stock had hit a 52-week high of Rs 76.15 on 7 September 2016. The stock had hit a 52-week low of Rs 41.35 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 September 2016, rising 5.73% compared with 1.85% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 26.79% as against Sensexs 5.57% rise.

The large-cap private-sector bank has equity capital of Rs 343.97 crore. Face value per share is Rs 2.

Federal Banks net profit rose 18.33% to Rs 167.31 crore on 6.82% rise in total income to Rs 2250.81 crore in Q1 June 2016 over Q1 June 2015.

Federal Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

Aurobindo Pharma gains after receiving tentative approval from USFDA for drug
Sep 22,2016

The announcement was made during trading hours today, 22 September 2016.

Meanwhile, the S&P BSE Sensex was up 232.98 points or 0.82% at 28,740.40.

High volumes were witnessed on the counter. On BSE, so far 4.4 lakh shares were traded in the counter as against average daily volume of 1.64 lakh shares in the past one quarter. The stock hit a high of Rs 846.90 and a low of Rs 811.50 so far during the day. The stock had hit a record high of Rs 891.50 on 30 December 2015. The stock had hit a 52-week low of Rs 582 on 25 February 2016. The stock had outperformed the market over the past one month till 21 September 2016, gaining 5.57% compared with 1.53% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 11.65% as against Sensexs 6.32% rise.

The large-cap company has equity capital of Rs 58.52 crore. Face value per share is Re 1.

Aurobindo Pharma said that this important milestone marks the first US Food & Drug Administration (USFDA) approval of a generic version of Dolutegravir (DTG), an integrase strand transfer inhibitor recommended for use in treatment-nan++ve patients by the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). Through an innovative collaboration with ViiV and the Clinton Health Access Initiative, Inc. (CHAI), the product is expected to be launched in sub-Saharan Africa in late 2016. The approved Abbreviated New Drug Application (ANDA) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Tivicay, of ViiV Healthcare. ViiV Healthcare and Aurobindo Pharma signed a licensing agreement in 2014 that allows Aurobindo Pharma to supply Dolutegravir 50mg in 92 licensed countries, following completion of required local regulatory approval processes.

Dolutegravir 50mg is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.

Aurobindo Pharmas consolidated net profit rose 23.8% to Rs 584.96 crore on 13% growth in net sales to Rs 3663.91 crore in Q1 June 2016 over Q1 June 2015.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The companys robust product portfolio is spread over 7 major therapeutic/product areas encompassing antibiotics, anti-retrovirals, CVS, CNS, gastroenterologicals, anti-allergies and anti-diabetics, supported by an outstanding R&D set-up. The company is marketing these products globally, in over 150 countries.

Powered by Capital Market - Live News

Volumes jump at Ahluwalia Contracts (India) counter
Sep 22,2016

Ahluwalia Contracts (India) clocked volume of 2.57 lakh shares by 13:20 IST on BSE, a 70.82-times surge over two-week average daily volume of 4,000 shares. The stock was up 1.41% at Rs 295.25.

D-Link (India) notched up volume of 6.21 lakh shares, a 35.01-fold surge over two-week average daily volume of 18,000 shares. The stock surged 17.26% at Rs 88.65.

Gujarat Pipavav Port saw volume of 19.03 lakh shares, a 29.61-fold surge over two-week average daily volume of 64,000 shares. The stock declined 0.29% at Rs 172.

Sadbhav Infrastructure Project clocked volume of 24.66 lakh shares, a 24.33-fold surge over two-week average daily volume of 1.01 lakh shares. The stock jumped 10.87% at Rs 112.75 after the company said it raised Rs 200 crore under tranche 1 by issue of non-convertible debentures on private placement basis. The announcement was made during market hours today, 22 September 2016.

Asahi Songwon Colors saw volume of 8.52 lakh shares, a 22.21-fold rise over two-week average daily volume of 38,000 shares. The stock surged 11.05% at Rs 228.05.

Powered by Capital Market - Live News